Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration

Neuron

Volumn 41, Issue 5, 2004, Pages 687-699

  Sopher, Bryce L ^a   Thomas Jr , Patrick S ^a   Lafevre Bernt, Michelle A ^b   Holm, Ida E ^a   Wilke, Scott A ^a   Ware, Carol B ^a   Jin, Lee Way ^a   Libby, Randell T ^a   Ellerby, Lisa M ^b   La Spada, Albert R ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; FEMALE; KENNEDY DISEASE; MALE; MOTONEURON; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; MOUSE; NERVE CELL; NERVE CELL DEGENERATION; NEUROTOXICITY; NEUROTROPISM; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN BINDING; STEM CELL; SURVIVAL RATE; TRANSGENIC MOUSE; X CHROMOSOME LINKAGE; YEAST;

ANIMALS; CELL LINE; CHROMOSOMES, ARTIFICIAL, YEAST; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; NERVE DEGENERATION; RECEPTORS, ANDROGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 12144286872     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(04)00082-0     Document Type: Article

References (47)

1. Abel A., Walcott J., Woods J., Duda J., Merry D.E. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum. Mol. Genet. 10:2001;107-116.
2. Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Do J., Sang C., Kobayashi Y., Doyu M., Sobue G. Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum. Mol. Genet. 10:2001;1039-1048.
3. Arbizu T., Santamaria J., Gomez J.M., Quilez A., Serra J.P. A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. J. Neurol. Sci. 59:1983;371-382.
4. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 384:1996;641-643.
5. Bates G.P., Mangiarini L., Mahal A., Davies S.W. Transgenic models of Huntington's disease. Hum. Mol. Genet. 6:1997;1633-1637.
6. Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H., Poellinger L. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell. Biol. 20:2000;402-415.
7. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice. experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests Brain Res. 835:1999;18-26.
8. Dames S.A., Martinez-Yamout M., De Guzman R.N., Dyson H.J., Wright P.E. Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. USA. 99:2002;5271-5276.
9. Dunah A.W., Jeong H., Griffin A., Kim Y.M., Standaert D.G., Hersch S.M., Mouradian M.M., Young A.B., Tanese N., Krainc D. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science. 296:2002;2238-2243.
10. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9:2003;669-676.
11. Freedman S.J., Sun Z.Y., Poy F., Kung A.L., Livingston D.M., Wagner G., Eck M.J. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci. USA. 99:2002;5367-5372.
12. Freiman R.N., Tjian R. Neurodegeneration. A glutamine-rich trail leads to transcription factors. Science. 296:2002;2149-2150.
13. Garden G.A., Libby R.T., Fu Y.H., Kinoshita Y., Huang J., Possin D.E., Smith A.C., Martinez R.A., Fine G.C., Grote S.K.et al. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. J. Neurosci. 22:2002;4897-4905.
14. Gosztonyi G., Naschold U., Grozdanovic Z., Stoltenburg-Didinger G., Gossrau R. Expression of Leu-19 (CD56, N-CAM) and nitric oxide synthase (NOS) I in denervated and reinnervated human skeletal muscle. Microsc. Res. Tech. 55:2001;187-197.
15. Jakobovits A., Moore A.L., Green L.L., Vergara G.J., Maynard-Currie C.E., Austin H.A., Klapholz S. Germ-line transmission and expression of a human-derived yeast artificial chromosome. Nature. 362:1993;255-258.
16. Jiang H., Nucifora F.C. Jr., Ross C.A., DeFranco D.B. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum. Mol. Genet. 12:2003;1-12.
17. Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Sang C., Kobayashi Y., Doyu M., Sobue G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 35:2002;843-854.
18. Kennedy W.R., Alter M., Sung J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 18:1968;671-680.
19. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., Roberts S.G., Green M.R., Goodman R.H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:1994;223-226.
20. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 352:1991;77-79.
21. La Spada A.R., Roling D.B., Harding A.E., Warner C.L., Spiegel R., Hausmanowa Petrusewicz I., Yee W.C., Fischbeck K.H. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 2:1992;301-304.
22. La Spada A.R., Peterson K.R., Meadows S.A., McClain M.E., Jeng G., Chmelar R.S., Haugen H.A., Chen K., Singer M.J., Moore D.et al. Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability. Hum. Mol. Genet. 7:1998;959-967.
23. La Spada A.R., Fu Y., Sopher B.L., Libby R.T., Wang X., Li L.Y., Einum D.D., Huang J., Possin D.E., Smith A.C.et al. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron. 31:2001;913-927.
24. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I.et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34:2003;383-394.
25. Li S.H., Cheng A.L., Zhou H., Lam S., Rao M., Li H., Li X.J. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell. Biol. 22:2002;1277-1287.
26. Lin X., Cummings C.J., Zoghbi H.Y. Expanding our understanding of polyglutamine diseases through mouse models. Neuron. 24:1999;499-502.
27. Livak K.J., Flood S.J., Marmaro J., Giusti W., Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 4:1995;357-362.
28. Louissaint A. Jr., Rao S., Leventhal C., Goldman S.A. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron. 34:2002;945-960.
29. Marbini A., Ferrari A., Cioni G., Bellanova M.F., Fusco C., Gemignani F. Immunohistochemical study of muscle biopsy in children with cerebral palsy. Brain Dev. 24:2002;63-66.
30. Mariotti C., Castellotti B., Pareyson D., Testa D., Eoli M., Antozzi C., Silani V., Marconi R., Tezzon F., Siciliano G.et al. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females. a clinical and molecular study of 30 families Neuromuscul. Disord. 10:2000;391-397.
31. McCampbell A., Taylor J.P., Taye A.A., Robitschek J., Li M., Walcott J., Merry D., Chai Y., Paulson H., Sobue G., Fischbeck K.H. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9:2000;2197-2202.
32. McManamny P., Chy H.S., Finkelstein D.I., Craythorn R.G., Crack P.J., Kola I., Cheema S.S., Horne M.K., Wreford N.G., O'Bryan M.K.et al. A mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 11:2002;2103-2111.
33. Merry D.E., Kobayashi Y., Bailey C.K., Taye A.A., Fischbeck K.H. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 7:1998;693-701.
34. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
35. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S.et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28:2001;131-138.
36. Ringel S.P., Lava N.S., Treihaft M.M., Lubs M.L., Lubs H.A. Late-onset X-linked recessive spinal and bulbar muscular atrophy. Muscle Nerve. 1:1978;297-307.
37. Ruohola J.K., Valve E.M., Karkkainen M.J., Joukov V., Alitalo K., Harkonen P.L. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol. Cell. Endocrinol. 149:1999;29-40.
38. Salazar-Grueso E.F., Kim S., Kim H. Embryonic mouse spinal cord motor neuron hybrid cells. Neuroreport. 2:1991;505-508.
39. Schmidt B.J., Greenberg C.R., Allingham-Hawkins D.J., Spriggs E.L. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology. 59:2002;770-772.
40. Simental J.A., Sar M., Lane M.V., French F.S., Wilson E.M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266:1991;510-518.
41. Sobue G., Doyu M., Kachi T., Yasuda T., Mukai E., Kumagai T., Mitsuma T. Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy. J. Neurol. Sci. 117:1993;74-78.
42. Sopher B.L., Myrick S.B., Hong J.Y., Smith A.C., La Spada A.R. In vivo expansion of trinucleotide repeats yields plasmid and YAC constructs for targeting and transgenesis. Gene. 261:2000;383-390.
43. Takeyama K., Ito S., Yamamoto A., Tanimoto H., Furutani T., Kanuka H., Miura M., Tabata T., Kato S. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron. 35:2002;855-864.
44. Taylor M.D., Vancura R., Patterson C.L., Williams J.M., Riekhof J.T., Wright D.E. Postnatal regulation of limb proprioception by muscle-derived neurotrophin-3. J. Comp. Neurol. 432:2001;244-258.
45. Watase K., Weeber E.J., Xu B., Antalffy B., Yuva-Paylor L., Hashimoto K., Kano M., Atkinson R., Sun Y., Armstrong D.L.et al. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron. 34:2002;905-919.
46. Zhou Z.X., Sar M., Simental J.A., Lane M.V., Wilson E.M. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J. Biol. Chem. 269:1994;13115-13123.
47. Zhou Z.X., Lane M.V., Kemppainen J.A., French F.S., Wilson E.M. Specificity of ligand-dependent androgen receptor stabilization. receptor domain interactions influence ligand dissociation and receptor stability Mol. Endocrinol. 9:1995;208-218.